Loading...
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll, P Reichardt, P Le Cesne, A Bonvalot, S Azzarelli, A Hoekstra, H Leahy, Michael G Van Coevorden, F Verweij, J Hogendoorn, P
Woll, P
Reichardt, P
Le Cesne, A
Bonvalot, S
Azzarelli, A
Hoekstra, H
Leahy, Michael G
Van Coevorden, F
Verweij, J
Hogendoorn, P
Citations
Altmetric:
Abstract
The effect of adjuvant chemotherapy on survival for resected soft-tissue sarcoma remains unknown. We investigated the effect of intensive adjuvant chemotherapy on survival in patients after resection of high-risk soft-tissue sarcomas.
Affiliation
Description
Date
2012-10
Publisher
Collections
Keywords
Type
Article
Citation
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. 2012, 13 (10):1045-54 Lancet Oncol